
Lisa Gill
Stock Analyst at J.P. Morgan
(4.66)
# 862
Out of 5,152 analysts
444
Total ratings
61.2%
Success rate
9.1%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMDA Omada Health | Rated: Buy | $30 → $25 | $13.17 | +89.83% | 3 | Nov 16, 2026 | |
| LFST LifeStance Health Group | Reiterated: Hold | $13 → $15 | $13.77 | +8.93% | 14 | Nov 12, 2026 | |
| MDLN Medline | Reiterated: Buy | $46 → $47 | $39.16 | +20.02% | 4 | Nov 12, 2026 | |
| CAH Cardinal Health | Reiterated: Hold | $260 → $286 | $278.32 | +2.76% | 25 | Nov 10, 2026 | |
| COR Cencora | Reiterated: Buy | $390 → $413 | $348.31 | +18.57% | 29 | Nov 10, 2026 | |
| HUM Humana | Reiterated: Hold | $393 → $484 | $385.78 | +25.46% | 24 | Nov 10, 2026 | |
| MCK McKesson | Reiterated: Buy | $1,042 → $1,255 | $1,084.43 | +15.73% | 48 | Nov 10, 2026 | |
| PGNY Progyny | Rated: Hold | $30 → $35 | $36.16 | -3.21% | 6 | Nov 9, 2026 | |
| TDOC Teladoc Health | Rated: Hold | $7 → $10 | $8.06 | +24.07% | 29 | Oct 30, 2026 | |
| DGX Quest Diagnostics | Reiterated: Hold | $250 → $260 | $259.69 | +0.12% | 20 | Oct 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $516 → $524 | $349.91 | +49.75% | 30 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 | $31.71 | +4.07% | 17 | Oct 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $370.78 | - | 16 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $21 → $85 | $90.53 | -6.11% | 16 | Aug 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 | $81.35 | +45.05% | 33 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $285.37 | - | 22 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $411 → $476 | $400.84 | +18.75% | 19 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 → $35 | $24.60 | +42.28% | 18 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.36 | - | 8 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $23 | $6.72 | +242.26% | 12 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $6 → $10 | $10.85 | n/a | 6 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $31 | $41.98 | n/a | 3 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $27.54 | n/a | 1 | Jun 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $28 → $27 | $26.96 | n/a | 9 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $110 | $95.43 | n/a | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $6 → $5 | $8.91 | n/a | 7 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 → $18 | $46.30 | n/a | 3 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $82 → $80 | $67.45 | n/a | 2 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $19 | $14.40 | n/a | 2 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $257 → $379 | $476.35 | n/a | 5 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $378 | $206.56 | n/a | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $172 | $271.34 | n/a | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $226 | $186.07 | n/a | 1 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $88 → $83 | $85.69 | n/a | 5 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $9 | $4.17 | n/a | 1 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $3.93 | n/a | 2 | Aug 5, 2016 |
Omada Health
Nov 16, 2026
Rated: Buy
Price Target: $30 → $25
Current: $13.17
Upside: +89.83%
LifeStance Health Group
Nov 12, 2026
Reiterated: Hold
Price Target: $13 → $15
Current: $13.77
Upside: +8.93%
Medline
Nov 12, 2026
Reiterated: Buy
Price Target: $46 → $47
Current: $39.16
Upside: +20.02%
Cardinal Health
Nov 10, 2026
Reiterated: Hold
Price Target: $260 → $286
Current: $278.32
Upside: +2.76%
Cencora
Nov 10, 2026
Reiterated: Buy
Price Target: $390 → $413
Current: $348.31
Upside: +18.57%
Humana
Nov 10, 2026
Reiterated: Hold
Price Target: $393 → $484
Current: $385.78
Upside: +25.46%
McKesson
Nov 10, 2026
Reiterated: Buy
Price Target: $1,042 → $1,255
Current: $1,084.43
Upside: +15.73%
Progyny
Nov 9, 2026
Rated: Hold
Price Target: $30 → $35
Current: $36.16
Upside: -3.21%
Teladoc Health
Oct 30, 2026
Rated: Hold
Price Target: $7 → $10
Current: $8.06
Upside: +24.07%
Quest Diagnostics
Oct 29, 2026
Reiterated: Hold
Price Target: $250 → $260
Current: $259.69
Upside: +0.12%
Oct 16, 2026
Rated: Buy
Price Target: $516 → $524
Current: $349.91
Upside: +49.75%
Oct 10, 2026
Downgraded: Hold
Price Target: $33
Current: $31.71
Upside: +4.07%
Aug 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $370.78
Upside: -
Aug 24, 2026
Reiterated: Sell
Price Target: $21 → $85
Current: $90.53
Upside: -6.11%
Aug 12, 2026
Reiterated: Buy
Price Target: $118
Current: $81.35
Upside: +45.05%
Jul 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $285.37
Upside: -
Jun 8, 2026
Reiterated: Buy
Price Target: $411 → $476
Current: $400.84
Upside: +18.75%
Mar 6, 2026
Reiterated: Buy
Price Target: $33 → $35
Current: $24.60
Upside: +42.28%
Feb 26, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.36
Upside: -
Dec 17, 2025
Reiterated: Buy
Price Target: $20 → $23
Current: $6.72
Upside: +242.26%
Sep 18, 2025
Upgraded: Hold
Price Target: $6 → $10
Current: $10.85
Upside: n/a
Aug 21, 2025
Reiterated: Buy
Price Target: $30 → $31
Current: $41.98
Upside: n/a
Jun 6, 2025
Initiated Coverage: Buy
Price Target: n/a
Current: $27.54
Upside: n/a
May 16, 2025
Reiterated: Hold
Price Target: $28 → $27
Current: $26.96
Upside: n/a
Mar 19, 2025
Reiterated: Buy
Price Target: $120 → $110
Current: $95.43
Upside: n/a
Dec 17, 2024
Downgraded: Sell
Price Target: $6 → $5
Current: $8.91
Upside: n/a
Dec 17, 2024
Downgraded: Hold
Price Target: $40 → $18
Current: $46.30
Upside: n/a
Nov 12, 2024
Reiterated: Hold
Price Target: $82 → $80
Current: $67.45
Upside: n/a
Aug 30, 2024
Reiterated: Hold
Price Target: $18 → $19
Current: $14.40
Upside: n/a
Aug 9, 2024
Reiterated: Hold
Price Target: $257 → $379
Current: $476.35
Upside: n/a
Aug 9, 2024
Reiterated: Buy
Price Target: $378
Current: $206.56
Upside: n/a
Aug 9, 2024
Reiterated: Buy
Price Target: $172
Current: $271.34
Upside: n/a
Aug 9, 2024
Reiterated: Hold
Price Target: $226
Current: $186.07
Upside: n/a
Aug 9, 2023
Reiterated: Hold
Price Target: $88 → $83
Current: $85.69
Upside: n/a
Jul 12, 2021
Downgraded: Sell
Price Target: $9
Current: $4.17
Upside: n/a
Aug 5, 2016
Reiterated: Buy
Price Target: $26
Current: $3.93
Upside: n/a